SEC Tracker
Get the app

Oruka Therapeutics ORKA

Quinlan Paul (Officer) plans to sell 71,000 ORKA shares, about $7.7M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Aug 14, 2026
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Exercise of Stock Options
  4. 10b5-1 plan adopted: May 15, 2026

All of Quinlan Paul's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 3,630 shares at $106.05 on Aug 14, 2026 · Form 4
  • Sold 10,434 shares at $107.14 on Aug 14, 2026 · Form 4
  • Sold 14,696 shares at $107.97 on Aug 14, 2026 · Form 4
  • Sold 10,200 shares at $109.11 on Aug 14, 2026 · Form 4
  • Sold 9,193 shares at $110 on Aug 14, 2026 · Form 4
  • Sold 3,847 shares at $111.14 on Aug 14, 2026 · Form 4
  • Sold 1,039 shares at $95.71 on Sep 15, 2026 · Form 4
  • Sold 2,900 shares at $92.37 on Sep 21, 2026 · Form 4
  • Sold 3,832 shares at $93.32 on Sep 21, 2026 · Form 4
  • Sold 601 shares at $94.44 on Sep 21, 2026 · Form 4
  • Sold 2,667 shares at $95.31 on Sep 21, 2026 · Form 4
  • Sold 400 shares at $74.9 on Oct 20, 2026 · Form 4
  • Sold 500 shares at $76.12 on Oct 20, 2026 · Form 4
  • Sold 1,000 shares at $77.21 on Oct 20, 2026 · Form 4
  • Sold 4,100 shares at $78.79 on Oct 20, 2026 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Oruka Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. CytomX Therapeutics CTMX public float $372M, Jun 30, 2025
  2. Cronos Group CRON public float $380M, Jun 30, 2025
  3. REGENXBIO RGNX public float $385M, Jun 30, 2025
  4. Capricor Therapeutics CAPR public float $399M, Jun 30, 2025
  5. Cryoport CYRX public float $400M, Jun 30, 2025